LIXT
Closed
Lixte Biotechnology Holdings Inc
1.18
+0.28 (+30.94%)
Last Update: 01 Jul 2025 23:28:00
Yesterday: 0.905
Day's Range: 0.901 - 1.54
Send
sign up or login to leave a comment!
When Written:
0.92
Lixte Biotechnology Holdings Inc is a clinical-stage biotechnology company that focuses on the development of novel drugs for the treatment of cancer. The company's lead drug candidate, LB-100, is a small molecule inhibitor of protein phosphatase 2A (PP2A), an enzyme that plays a critical role in the regulation of cell growth and survival. LB-100 has shown promising results in preclinical studies and is currently being evaluated in clinical trials for the treatment of various types of cancer.
Lixte Biotechnology Holdings Inc was founded in 2005 and is headquartered in East Setauket, New York. The company's mission is to develop innovative therapies that can improve the lives of cancer patients. Lixte Biotechnology Holdings Inc is listed on the Nasdaq Capital Market under the ticker symbol "LIXT".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Lixte Biotechnology Holdings Inc was founded in 2005 and is headquartered in East Setauket, New York. The company's mission is to develop innovative therapies that can improve the lives of cancer patients. Lixte Biotechnology Holdings Inc is listed on the Nasdaq Capital Market under the ticker symbol "LIXT".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








